The Hawryluk Biopharmaceutical Scholars
A passion for improving healthcare
Established in February 2021, the Hawryluk Scholars Endowed Fund is awarded to a handful of Kellogg MBA students who have a proven interest in the biopharmaceutical field. With the opportunity to learn from Kellogg alumni and other experts currently working in the healthcare management field — particularly in the cutting-edge specialty of biopharmaceuticals — you'll get an immersive education, access to industry leaders and a dedicated mentor.
Kent Hawryluk ’07 Executive MBA, co-founder, president and CEO of MBX Biosciences, started the Hawryluk Biopharmaceutical Scholars Endowed Fund believing that Kellogg is in a unique position to nurture a pipeline of MBA talent in healthcare, biopharmaceuticals and support-related entrepreneurship.
A Cutting-edge scholarship
Get ongoing, personalized guidance from alumni and scholarship cohorts.
Enjoy personalized access to industry leaders and startups.
Visit leading-edge companies at the forefront of biopharmaceutical innovation.In April 2023, the Hawryluk Scholars traveled to Boston, Massachusetts, for a trek through the city’s biopharma ecosystem. Read article on their visit Two Hawryluk Scholars Eager to Change the Future of Biopharma